Journal of International Oncology››2012,Vol. 39››Issue (11): 848-850.

Previous ArticlesNext Articles

EML4-ALK fusion gene in non-small cell lung cancer

WANG Meng, YANG Ji-Yuan

  1. Department of Medical Oncology,the First AffiliatedHospital,Yangtze University ,Jingzhou 434100,China
  • Online:2012-11-08Published:2012-11-16

Abstract:EML4-ALK fusion oncogene represents a new molecular target which appears mainly in lung adenocarcinoma. EML4-ALK is detected more frequently in young non-small-cell lung cancer patients who never or light smoke. ALK inhibitors(crizotinib)for the treatment of the EML4-ALK-positive non-small cell lung cancer has a high response rate. This finding can improve the individual treatment of non-small cell lung cancer.

Key words:Carcinoma, non-small-cell,Lung neoplasms,Tumor markers